Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More
Marico - The strongest branding play - Antique

A strong play on rural consumerism

Our interactions across our five sample states, re-affirmed our belief in Marico's dominance in coconut and hair oils. The company is capitalising on the opportunity of shift in preference towards branded coconut and hair oils in rural markets. This would be done through expanding its rural exposure during the last three years from about 27% to the current 32%.

Strong pricing power to aid margins

Pricing power of Parachute coconut oil, its key profit generator has been the success factor during the past few years. The brands strength and pricing power led to a substantial 454 bps improvement in Marico's margins from 8.8% in FY05 to 12.9% in FY08. Additionally during FY11 and FY12, years of steep inflation, the brand re-affirmed its strength by recording a volume growth of 11% despite a price hike of 32% in the last 12 months. During FY13, we expect the pricing power of Parachute coupled with drop in copra prices to expand EBITDA margins by 204bps to 14.2%.

Increasing dominance in coconut oil

Marico witnessed a marked improvement over its long term performance by gaining ground in the coconut oil segment where market shares across companies normally remain stagnant. In the coconut oil category Parachute gained about 300bps market share during 1QFY13.

Gaining ground in value added hair oils

Marico has successfully expanded the value added hair oils business through aggressive marketing and entry in to newer categories. This in turn has led to market share gains to the tune of 780bps to 24.8% during the last 5 years. Our channel checks suggest that a majority of the market share gains have been led by improvement in the South Indian market.

Acquisition of Paras Pharma's personal care biz to aid scalability

The acquisition provides the company meaningful entry in a fast growing category like Deodorant and strengthens its market share in hair styling gel and creams. The acquisition also provides Marico an entry in to a better margin profile business when compared to its existing business like hair oils and health based edible oil. Parachute coconut oil nevertheless has a high margin profile.

Valuation

We maintain our earnings estimates for FY13e and FY14e at INR7.2 and INR8.6 respectively. At the CMP of INR203, the stock is trading at a PE of 28.3x FY13e and 23.5x FY14e. We maintain our target price of INR198. In the current scenario, we don't see any scope for further upgrade in the stock or any case for further re-rating. We therefore maintain our HOLD rating on the stock with a target price of INR198.

Source: Equity Bulls

Posted On: 2012-11-01 20:27:52

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Surana Industries Ltd posts Q1 loss of Rs. 10.80 crores
Ricoh India - Stock Review - Sushil Finance
Minda Industries Ltd - Q4 FY14 Result - Quick View - CMP Rs.277, Maintain BUY - Sushil Finance
Road Ministry approves over Rs. 40,000 crore highway projects - Angel Broking
UPL - 50% stake sale in the Brazilian Agrochemical company - Angel Broking
UPL - stake sale in Brazilian company - Angel Broking
Cipla in US $14mn deal with Sri Lankan distributor firm - Angel Broking
Triveni Turbine Ltd - Q4 & FY14 Result - Quick View - CMP Rs.95, Maintain HOLD - Sushil Finance
City Union Bank Ltd. - Q4FY14 Update, CMP Rs.71, Rating Changed to HOLD with revised Target of Rs.72 - Sushil Finance
Vishal Sikka will take over as CEO and MD of Infosys - Angel Broking
Views on State Bank of India 4QFY2014 results - Angel Broking
Views on Ashok Leyland 4QFY2014 results - Angel Broking
Views on Motherson Sumi Systems 4QFY2014 results - Angel Broking
Views on Ramco Cements 4QFY2014 results - Angel Broking
Views on UCO Bank 4QFY2014 results - Angel Broking
USFDA letter to Sun Pharma's response on the import alert on its karkhadi plant - Angel Broking
Views On Cadila Healthcare results - Angel Broking
Views on Apollo Tyres results - Angel Broking
Views on Jammu and Kashmir Bank - Angel Broking
Views on Bank Of India results - Angel Broking
Views on Bajaj Auto 4QFY2014 results - Angel Broking
Views on Sun Pharma announces settlement of litigation for generic Gleevec in US - Angel Broking
Alicon Castalloy Ltd. - Q4 FY14 Result Update - CMP Rs.131 - Rating Changed to BUY for increased target of Rs.189 - Sushil Finance
Petronet LNG Ltd - Q4FY14 Update-CMP Rs.145, Rating Changed to HOLD, Target increased to Rs.152 - Sushil Finance
European regulator lifts drug export ban from Ranbaxy Laboratories' Toansa plant - Angel Broking
Angel Broking recommends Neutral on Aurobindo Pharma - 4QFY2014 Result Update
Angel Broking recommends Buy on Bajaj Electricals with a Target Price of Rs. 441
Angel Broking recommends Buy on Dishman Pharmaceuticals with a Target Price of Rs. 123
Atul Auto Ltd. - Q4 FY14 Result Update - CMP Rs.384 - Rating Changed To Buy For Increased Target of Rs.469- INVESt VISTa
Angel Broking recommends Accumulate on Ipca Labs with a Target Price of Rs. 882
Angel Broking recommends Buy on Sun Pharma with a Target Price of Rs. 706
Angel Broking recommends Buy on Cipla with a Target Price of Rs. 431
Angel Broking recommends Buy on Siyaram Silk Mills with a Target Price of Rs. 602
Angel Broking recommends Accumulate on Hero MotoCorp with a Target Price of Rs. 2,640
Angel Broking recommends Buy on Jagran Prakashan with a 12 months Target Price of Rs. 140
Angel Broking recommends Accumulate on ITC with a 12 months Target Price of Rs. 382
Angel Broking recommends Neutral on UCO Bank - 4QFY2014 Result Update
Views on Larsen & Toubro 4QFY2014 results - Angel Broking
Views on Mahindra & Mahindra 4QFY2014 results - Angel Broking
Views on Cipla 4QFY2014 results - Angel Broking
Views on Tata Motors 4QFY2014 results - Angel Broking
Views on BHEL 4QFY2014 results - Angel Broking
Angel Broking recommends Neutral on Indoco Remedies - 4QFY2014 Result Update
Views on Page Industries 4QFY2014 results - Angel Broking
Views on Sun Pharmaceuticals 4QFY2014 results - Angel Broking
Views on Bajaj Electricals Ltd 4QFY2014 results - Angel Broking
Views on IPCA Labs 4QFY2014 results - Angel Broking
Angel Broking recommends Accumulate on SUN TV Network with a 12 months Target Price of Rs 460
Kirloskar Oil Engines Ltd. - Stock Review - May 2014 - Sushil Finance
President and Member of Board, Infosys resigns - Angel Broking




  

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014